Ferrante Jeanne M, Ohman-Strickland Pamela, Hudson Shawna V, Hahn Karissa A, Scott John G, Crabtree Benjamin F
Department of Family Medicine, UMDNJ-New Jersey Medical School, NJ 07101-1709, USA.
Cancer Detect Prev. 2006;30(5):459-65. doi: 10.1016/j.cdp.2006.09.003. Epub 2006 Oct 25.
Obesity is associated with increased colorectal cancer incidence and mortality. Previous studies using telephone survey data showed that obese women were less likely to receive colorectal cancer screening. It is unknown if this is true among patients in primary care practices.
Retrospective chart reviews were conducted in 2003-2004 of men and women in 22 suburban New Jersey and Pennsylvania primary care practices. Data from patients age 50 years and over (n=1297) were analyzed using hierarchical logistic regression. The outcome measure was receipt of colorectal cancer screening (fecal occult blood test within 1 year, sigmoidoscopy within 5 years, colonoscopy within 10 years, or barium enema within 5 years) among obese and non-obese patients.
Overall, 39% of patients were obese and 29% received colorectal cancer screening. After controlling for age, gender, total number of co-morbidities, number of visits in the past 2 years, and number of years in the practice, obese patients had 25% decreased odds of being screened for colorectal cancer compared to non-obese patients (OR 0.75, 95% CI, 0.62-0.91). The relationship of obesity and colorectal cancer screening did not differ according to gender. Number of visits (OR 1.04, 95% CI, 1.01-1.06) and male gender (OR 1.53, 95% CI, 1.19-1.97) was associated with increased odds of receiving colorectal cancer screening.
Identification of physician and patient barriers to colorectal cancer screening is needed, particularly in obese patients, so that effective interventions may be developed to increase screening in this high-risk group.
肥胖与结直肠癌发病率和死亡率的增加相关。以往使用电话调查数据的研究表明,肥胖女性接受结直肠癌筛查的可能性较小。在初级医疗实践中的患者中情况是否如此尚不清楚。
2003 - 2004年对新泽西州和宾夕法尼亚州郊区22家初级医疗诊所的男性和女性进行了回顾性病历审查。使用分层逻辑回归分析了50岁及以上患者(n = 1297)的数据。结局指标是肥胖和非肥胖患者接受结直肠癌筛查的情况(1年内进行粪便潜血试验、5年内进行乙状结肠镜检查、10年内进行结肠镜检查或5年内进行钡灌肠)。
总体而言,39%的患者肥胖,29%接受了结直肠癌筛查。在控制年龄、性别、共病总数、过去两年就诊次数和在该诊所就诊年限后,与非肥胖患者相比,肥胖患者接受结直肠癌筛查的几率降低了25%(比值比0.75,95%可信区间,0.62 - 0.91)。肥胖与结直肠癌筛查的关系在性别上没有差异。就诊次数(比值比1.04,95%可信区间,1.01 - 1.06)和男性(比值比1.53,95%可信区间,1.19 - 1.97)与接受结直肠癌筛查几率的增加相关。
需要识别医生和患者在结直肠癌筛查方面的障碍,尤其是在肥胖患者中,以便制定有效的干预措施来增加这一高危人群的筛查率。